Correlation Between INtRON Biotechnology and Korea Investment

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both INtRON Biotechnology and Korea Investment at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining INtRON Biotechnology and Korea Investment into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between iNtRON Biotechnology and Korea Investment Holdings, you can compare the effects of market volatilities on INtRON Biotechnology and Korea Investment and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in INtRON Biotechnology with a short position of Korea Investment. Check out your portfolio center. Please also check ongoing floating volatility patterns of INtRON Biotechnology and Korea Investment.

Diversification Opportunities for INtRON Biotechnology and Korea Investment

-0.3
  Correlation Coefficient

Very good diversification

The 3 months correlation between INtRON and Korea is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding iNtRON Biotechnology and Korea Investment Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Korea Investment Holdings and INtRON Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on iNtRON Biotechnology are associated (or correlated) with Korea Investment. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Korea Investment Holdings has no effect on the direction of INtRON Biotechnology i.e., INtRON Biotechnology and Korea Investment go up and down completely randomly.

Pair Corralation between INtRON Biotechnology and Korea Investment

Assuming the 90 days trading horizon iNtRON Biotechnology is expected to under-perform the Korea Investment. In addition to that, INtRON Biotechnology is 1.63 times more volatile than Korea Investment Holdings. It trades about -0.07 of its total potential returns per unit of risk. Korea Investment Holdings is currently generating about 0.11 per unit of volatility. If you would invest  5,070,000  in Korea Investment Holdings on September 4, 2024 and sell it today you would earn a total of  390,000  from holding Korea Investment Holdings or generate 7.69% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

iNtRON Biotechnology  vs.  Korea Investment Holdings

 Performance 
       Timeline  
iNtRON Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days iNtRON Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
Korea Investment Holdings 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Korea Investment Holdings are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Korea Investment may actually be approaching a critical reversion point that can send shares even higher in January 2025.

INtRON Biotechnology and Korea Investment Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with INtRON Biotechnology and Korea Investment

The main advantage of trading using opposite INtRON Biotechnology and Korea Investment positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if INtRON Biotechnology position performs unexpectedly, Korea Investment can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Korea Investment will offset losses from the drop in Korea Investment's long position.
The idea behind iNtRON Biotechnology and Korea Investment Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Complementary Tools

Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk